University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Post-Thoracotomy Closure Study

Not Applicable

Completed

Conditions: Post Thoracotomy Pain Syndrome

Interventions: Procedure: Pericostal Closure Technique
Procedure: Intracostal Closure Technique

First Posted Date: 2013-07-12

Last Posted Date: 2020-12-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 90

Registration Number: NCT01898468

Locations: 🇨🇦
Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures

Phase 3

Completed

Conditions: Non Displaced Atypical Femoral Fractures

Interventions: Other: Placebo
Biological: Teriparatide 20 mcg

First Posted Date: 2013-07-11

Last Posted Date: 2023-06-01

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 34

Registration Number: NCT01896011

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer

Not Applicable

Completed

Conditions: Endometrial Cancer
Sentinel Lymph Node
Indocyanine Green

Interventions: Biological: Indocyanine Green (ICG)

First Posted Date: 2013-06-25

Last Posted Date: 2024-03-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 156

Registration Number: NCT01886066

Locations: 🇨🇦
Sunnybrook Health Sciences Center, Toronto, Ontario, Canada
🇨🇦
University Health Network - Princess Margaret Hospital, Toronto, Ontario, Canada

Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma

Phase 2

Completed

Conditions: Metastatic, Stage III or Stage IV, Melanoma

Interventions: Drug: Cyclophosphamide
Drug: Fludarabine
Biological: Tumor-Infiltrating Lymphocytes
Biological: Low-Dose Interleukin

First Posted Date: 2013-06-21

Last Posted Date: 2019-11-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 12

Registration Number: NCT01883323

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

"Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1

Active, not recruiting

Conditions: High Grade Serous Ovarian Cancer
Primary Peritoneal Cancer
Recurrent
Platinum-resistant
Fallopian Tube Cancer

Interventions: Biological: Re-stimulated tumor-infiltrating lymphocytes (TILs)
Biological: Interleukin-2
Drug: Cyclophosphamide

First Posted Date: 2013-06-21

Last Posted Date: 2024-03-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 3

Registration Number: NCT01883297

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Feasibility Study of the Adult Congenital Heart Disease-Coping and Resilience (ACHD-CARE) Trial

Not Applicable

Completed

Conditions: Heart Defects, Congenital

Interventions: Behavioral: ACHD-CARE Program

First Posted Date: 2013-06-20

Last Posted Date: 2015-12-24

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 42

Registration Number: NCT01881893

Locations: 🇨🇦
Toronto Congenital Cardiac Clinic for Adults, Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Ontario, Canada

Prostate Delineation: High Quality Volume CT

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Other: High Quality Volume CT Scan; MRI Scan

First Posted Date: 2013-06-17

Last Posted Date: 2017-08-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 10

Registration Number: NCT01878773

Locations: 🇨🇦
University Health Network, The Princess Margaret, Toronto, Ontario, Canada

Identifying Prostate Brachytherapy Seeds Using MRI

Not Applicable

Completed

Conditions: Prostate Cancer Patients Who Have Brachytherapy Seed Implant

Interventions: Other: MRI Scan

First Posted Date: 2013-06-14

Last Posted Date: 2016-11-01

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 10

Registration Number: NCT01878058

Locations: 🇨🇦
University Health Network, The Princess Margaret, Toronto, Ontario, Canada

The Metformin Active Surveillance Trial (MAST) Study

Phase 3

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: Placebo
Drug: Metformin

First Posted Date: 2013-05-29

Last Posted Date: 2024-01-24

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 408

Registration Number: NCT01864096

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇨🇦
London Health Sciences Centre-Victoria Hospital, London, Ontario, Canada
🇨🇦
MUHC - Montreal General Hospital, Montreal, Quebec, Canada

and more 9 locations

Canadian e-Platform to Promote Behavioral Self-Management in Chronic Heart Failure: CHF-CePPORT

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Behavioral: eCounseling + Usual Care

First Posted Date: 2013-05-29

Last Posted Date: 2021-07-06

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 248

Registration Number: NCT01864369

Locations: 🇨🇦
Montreal Heart Institute, Montreal, Quebec, Canada
🇨🇦
St.Paul's Hospital- UBC, Vancouver, British Columbia, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy